# Prevention of Arrhythmia Device Infection Trial (PADIT)

Study · id `cardio:ct-nct01613092` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01613092](<https://clinicaltrials.gov/study/NCT01613092>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01613092

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 241 participants.

## Technical summary

Registry record NCT01613092. Randomized; no masking; primary purpose prevention. Start 2011-05 (registry gives no type); primary completion 2013-11 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 241 participants (enrolled count; ClinicalTrials.gov record NCT01613092, source copy `cardio:ctgov-nct01613092-2014-10-10`, retrieved 2026-10-26)
- Start date: 2011-05 (registry gives no type) (ClinicalTrials.gov record NCT01613092, source copy `cardio:ctgov-nct01613092-2014-10-10`, retrieved 2026-10-26)
- Primary completion: 2013-11 (actual) (ClinicalTrials.gov record NCT01613092, source copy `cardio:ctgov-nct01613092-2014-10-10`, retrieved 2026-10-26)
- Completion: 2013-12 (actual) (ClinicalTrials.gov record NCT01613092, source copy `cardio:ctgov-nct01613092-2014-10-10`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT01613092, source copy `cardio:ctgov-nct01613092-2014-10-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01613092-2014-10-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: Prevention of Arrhythmia Device Infection Trial (PADIT)
- Condition: Arrhythmia
- Intervention (Drug): Incremental
- Intervention (Drug): Cefazolin
- Lead sponsor: Population Health Research Institute
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry lists this organization as the lead sponsor: Population Health Research Institute (`cardio:org-population-health-research-institute`)

## Provenance

Content hash: 497d213f1aee22ede69e633fc415a34166cea79bc28089ed1ccfbf28f3919b80
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
